接种宫颈癌疫苗是否有年龄限制,四价疫苗何时上市

2017-08-03 温潇潇 澎湃新闻

日前,大陆首个获批的预防宫颈癌的HPV疫苗正式上市,而此前,预防宫颈癌的主要手段是通过宫颈筛查。央视财经此前报道,该疫苗是英国制药企业葛兰素史克的“希瑞适”——针对两种可导致宫颈癌、风险最高的病毒株(HPV-16型和HPV-18型)的二价疫苗。对于该疫苗最佳接种年龄为9至25岁的说法,8月3日,山东大学齐鲁医院妇瘤科副主任张友忠在接受齐鲁晚报采访时表示,即使超过25岁,若没有感染过HPV病毒,或感

日前,大陆首个获批的预防宫颈癌的HPV疫苗正式上市,而此前,预防宫颈癌的主要手段是通过宫颈筛查

央视财经此前报道,该疫苗是英国制药企业葛兰素史克的“希瑞适”——针对两种可导致宫颈癌、风险最高的病毒株(HPV-16型和HPV-18型)的二价疫苗。

对于该疫苗最佳接种年龄为9至25岁的说法,8月3日,山东大学齐鲁医院妇瘤科副主任张友忠在接受齐鲁晚报采访时表示,即使超过25岁,若没有感染过HPV病毒,或感染的不是上述两种病毒,仍可以注射。

中国每年的宫颈癌病例占全球的28%以上,是妇女最常见的恶性肿瘤之一。在全球范围内,宫颈癌也是15岁至44岁女性中第三大高发癌症。

专家:超25岁有三种情况也可以打

国家食药监总局官网显示,HPV中文全称为人乳头瘤病毒。目前已知的100多种HPV中的大部分是“低风险”的,与宫颈癌无关联,但其中的14种被列为“高风险”,其中两种风险最高的病毒株(HPV-16型和HPV-18型)可导致约70%的宫颈癌。

此次上市的二价疫苗“希瑞适”的最佳接种年龄为9至25岁,很多超龄网友纷纷表示遗憾可惜,超过25岁的人群可以接种吗?

8月3日,山东大学齐鲁医院妇瘤科副主任张友忠在接受齐鲁晚报采访时表示,9-25岁只能理解为是打疫苗效果最好的年龄。实际上,有三种情况仍然可以注射这种疫苗:一是虽然超过25岁,但是没有感染过HPV病毒的;二是感染过HPV病毒,但感染的不是16、18这两种类型HPV病毒的;三是虽感染过HPV,发生过宫颈癌癌前病变,但是已经康复、转阴的。

据国家食药监总局公开资料,HPV感染在女性中较为普遍,有数据显示,在一生中的某个阶段,每5个女性中就有4个会感染。若感染的是高危型HPV,则有可能进展为高度的宫颈病变甚至发展成为宫颈癌。

HPV主要通过性接触传播,此外还可通过直接接触感染:比如手接触了带有HPV的物品后,在如厕、沐浴时有可能将病毒带入生殖器官;或者是生殖器官接触到带有HPV的浴巾等物品,都有可能被感染。

四价疫苗有望年底上市

据央视财经报道,一般宫颈癌疫苗,分为二价、四价、九价,这次获准在内地上市的,是葛兰素史克的HPV二价疫苗。

中国医学科学院肿瘤流行病学研究室主任乔友林在接受央视新闻采访时介绍,今年5月,四价疫苗(在二价疫苗的基础上增加两种HPV病毒针对性,适用年龄为20至45岁)已经得到国家认定批准,并有望于年底上市。

对于公众何时可以用上九价疫苗,乔友林表示,目前九价苗还没有进入临床实验,预计时间“非常漫长”。

HPV疫苗近期是否会纳入医保范围?中国医学科学院肿瘤医院肿瘤流行病学室副主任、教授、博士生导师赵方辉认为不太可能,只有通过市场竞争将疫苗的价格降下来,届时才有可能会纳入医保。

对于宫颈癌疫苗,国家食药监总局提醒,由于HPV病毒与宫颈癌相关的高危亚型有10多种,而疫苗针对的只是其中的某几种,所以即使接种了宫颈癌疫苗,仍然应定期筛查。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1663731, encodeId=f0621663e31e1, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Tue Nov 14 15:29:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989766, encodeId=4d121989e6655, content=<a href='/topic/show?id=77784042609' target=_blank style='color:#2F92EE;'>#四价疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40426, encryptionId=77784042609, topicName=四价疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sun Aug 13 19:29:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408048, encodeId=8dbb140804840, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sat Aug 05 11:29:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229795, encodeId=1246229e95bd, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Fri Aug 04 06:21:24 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229783, encodeId=978e229e83b7, content=学习一下,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri Aug 04 05:55:25 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229744, encodeId=72b3229e4485, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Aug 04 00:05:42 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1663731, encodeId=f0621663e31e1, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Tue Nov 14 15:29:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989766, encodeId=4d121989e6655, content=<a href='/topic/show?id=77784042609' target=_blank style='color:#2F92EE;'>#四价疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40426, encryptionId=77784042609, topicName=四价疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sun Aug 13 19:29:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408048, encodeId=8dbb140804840, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sat Aug 05 11:29:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229795, encodeId=1246229e95bd, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Fri Aug 04 06:21:24 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229783, encodeId=978e229e83b7, content=学习一下,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri Aug 04 05:55:25 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229744, encodeId=72b3229e4485, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Aug 04 00:05:42 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1663731, encodeId=f0621663e31e1, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Tue Nov 14 15:29:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989766, encodeId=4d121989e6655, content=<a href='/topic/show?id=77784042609' target=_blank style='color:#2F92EE;'>#四价疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40426, encryptionId=77784042609, topicName=四价疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sun Aug 13 19:29:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408048, encodeId=8dbb140804840, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sat Aug 05 11:29:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229795, encodeId=1246229e95bd, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Fri Aug 04 06:21:24 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229783, encodeId=978e229e83b7, content=学习一下,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri Aug 04 05:55:25 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229744, encodeId=72b3229e4485, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Aug 04 00:05:42 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
    2017-08-05 一闲
  4. [GetPortalCommentsPageByObjectIdResponse(id=1663731, encodeId=f0621663e31e1, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Tue Nov 14 15:29:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989766, encodeId=4d121989e6655, content=<a href='/topic/show?id=77784042609' target=_blank style='color:#2F92EE;'>#四价疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40426, encryptionId=77784042609, topicName=四价疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sun Aug 13 19:29:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408048, encodeId=8dbb140804840, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sat Aug 05 11:29:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229795, encodeId=1246229e95bd, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Fri Aug 04 06:21:24 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229783, encodeId=978e229e83b7, content=学习一下,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri Aug 04 05:55:25 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229744, encodeId=72b3229e4485, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Aug 04 00:05:42 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
    2017-08-04 130****4638

    学习了谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1663731, encodeId=f0621663e31e1, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Tue Nov 14 15:29:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989766, encodeId=4d121989e6655, content=<a href='/topic/show?id=77784042609' target=_blank style='color:#2F92EE;'>#四价疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40426, encryptionId=77784042609, topicName=四价疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sun Aug 13 19:29:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408048, encodeId=8dbb140804840, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sat Aug 05 11:29:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229795, encodeId=1246229e95bd, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Fri Aug 04 06:21:24 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229783, encodeId=978e229e83b7, content=学习一下,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri Aug 04 05:55:25 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229744, encodeId=72b3229e4485, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Aug 04 00:05:42 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
    2017-08-04 changjiu

    学习一下,谢谢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1663731, encodeId=f0621663e31e1, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Tue Nov 14 15:29:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989766, encodeId=4d121989e6655, content=<a href='/topic/show?id=77784042609' target=_blank style='color:#2F92EE;'>#四价疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40426, encryptionId=77784042609, topicName=四价疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e72268, createdName=zhixianchen, createdTime=Sun Aug 13 19:29:00 CST 2017, time=2017-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408048, encodeId=8dbb140804840, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Sat Aug 05 11:29:00 CST 2017, time=2017-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229795, encodeId=1246229e95bd, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Fri Aug 04 06:21:24 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229783, encodeId=978e229e83b7, content=学习一下,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Fri Aug 04 05:55:25 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229744, encodeId=72b3229e4485, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Aug 04 00:05:42 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
    2017-08-04 139****5926

    好好文章学习了

    0

相关资讯

时隔十年 宫颈癌疫苗今日获准在中国上市

时隔十年,已在全球百余个国家实施广泛接种的HPV(Human Papillomavirus, 人乳头瘤病毒)疫苗终于进入了中国市场。18日晨间,葛兰素史克(GSK)向第一财经独家确认,其“希瑞适®” (人乳头状瘤病毒疫苗[16型和18型])获得国家食药监总局(CFDA)的上市许可,成为国内首个获批用于预防宫颈癌的HPV疫苗。这就意味着,自2006年全球首支HPV疫苗后,中国女性终于可以通过注射疫苗

「缅怀」发明宫颈癌疫苗的中国人 - 周健博士 !

前天,葛兰素史克公司发布消息,该公司的人乳头状瘤病毒疫苗[16型和18型]“希瑞适”获得国家食药监总局的上市许可,明年初将正式登陆中国市场,成为大陆首个获批用于预防宫颈癌的HPV疫苗。可你知道吗,HPV疫苗发明者之一就是我们中国人——温州医科大学知名校友、已故免疫学家周健博士。1980年,德国科学家哈拉尔德·楚尔·豪森(Zur Hausen)证实,宫颈癌是由HPV感染所致。2008年,豪森因此发现

美指南推荐hrHPV用于宫颈癌初筛 我国加强HPV检测管理

由于我国人口众多、发展不平衡,宫颈癌已成为中国女性第二大最常见的肿瘤,发病率与死亡率居高不下且呈明显的年轻化趋势。近日,在广州举行的中华医学会妇科肿瘤学分会第十五次全国妇科肿瘤学学术会议上,中国工程院院士、北京协和医院妇产科郎景和教授,北京协和医院妇产科向阳教授,中山大学附属肿瘤医院妇科刘继红教授与众多妇科肿瘤领域专家共同探讨了宫颈癌的防治与筛查,并分享了国内外关于人乳头状瘤病毒(HPV)检测

好消息!我国内地宫颈癌疫苗上市销售

7月31日,英国某知名制药企业官网显示,中国内地首个宫颈癌疫苗(人乳头状瘤病毒HPV疫苗[16型和18型])在获批一年后正式上市销售,而且比香港的定价更便宜。小伙伴们再也不用飞去香港打疫苗了!

宫颈癌疫苗打不打?国际上更有效的预防宫颈癌办法是什么?

最近平台上有不少关于接种宫颈癌疫苗(也就是HPV疫苗)的询问和讨论,连我的合伙人Ciline也受朋友之托多次来询问关于宫颈癌疫苗接种建议,因为目前在中国大陆不能接种,很多女性表示要去香港去接种HPV疫苗(大约3000港币约合2000多人民币),说明大家对女性健康很关心,这是非常好的!但是马丁医生要提醒一下大家,接种了宫颈癌疫苗,不代表就100%预防了宫颈癌,因为当前的疫苗未能针对全部致癌的病毒

记住中国科学家周健:宫颈癌疫苗共同发明人

宫颈癌疫苗共同发明人:中国科学家周健 导读: 宫颈癌是由病毒感染而引发的癌症,是一种常见的女性癌症,发病率仅次于乳腺癌。每年,世界约有50万女性被诊断为宫颈癌,其中25万多人死亡。 1980年,德国科学家哈拉尔德·楚尔·豪森(Zur Hausen)证实,宫颈癌是由人乳头状瘤病毒(HPV)感染所致。 1991年,澳大利亚昆士兰大学免疫和代谢研究所的伊恩·弗雷泽和中国科学家周健合作,利